These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9383603)

  • 21. Antagonism of vasoconstriction induced by platelet-activating factor in guinea-pig perfused hearts by selective platelet-activating factor receptor antagonists.
    Piper PJ; Stewart AG
    Br J Pharmacol; 1987 Apr; 90(4):771-83. PubMed ID: 3034369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of coronary hyperconstriction in response to serotonin induced by X-irradiation in miniature pigs: increased constrictive response of medial smooth muscle.
    Hirakawa Y; Kuga T; Ohara Y; Hata H; Tomoike H; Takeshita A
    Heart Vessels; 1995; 10(4):190-6. PubMed ID: 8530323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of platelet activating factor in cardiac dysfunction, apoptosis and nitric oxide synthase mRNA expression in the ischemic-reperfused rabbit heart.
    Loucks EB; Godin DV; Walley KR; McManus BM; Rahimian R; Granville DJ; Hong JM; Aktary FM; Qayumi AK
    Can J Cardiol; 2003 Mar; 19(3):267-74. PubMed ID: 12677282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vasculoprotective role of inducible nitric oxide synthase at inflammatory coronary lesions induced by chronic treatment with interleukin-1beta in pigs in vivo.
    Fukumoto Y; Shimokawa H; Kozai T; Kadokami T; Kuwata K; Yonemitsu Y; Kuga T; Egashira K; Sueishi K; Takeshita A
    Circulation; 1997 Nov; 96(9):3104-11. PubMed ID: 9386181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An antagonist of platelet-activating factor suppresses endotoxin-induced tumor necrosis factor and mortality in mice pretreated with carrageenan.
    Ogata M; Matsumoto T; Koga K; Takenaka I; Kamochi M; Sata T; Yoshida S; Shigematsu A
    Infect Immun; 1993 Feb; 61(2):699-704. PubMed ID: 8423096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory effect of TCV-309, a novel platelet activating factor (PAF) antagonist, on endotoxin-induced disseminated intravascular coagulation in rats: possible role of PAF in tissue factor generation.
    Kawamura M; Terashita Z; Imura Y; Shino A; Nishikawa K
    Thromb Res; 1993 May; 70(4):281-93. PubMed ID: 8332959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endothelial vasodilator function is preserved at the spastic/inflammatory coronary lesions in pigs.
    Miyata K; Shimokawa H; Yamawaki T; Kunihiro I; Zhou X; Higo T; Tanaka E; Katsumata N; Egashira K; Takeshita A
    Circulation; 1999 Sep; 100(13):1432-7. PubMed ID: 10500045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutrophil-dependent augmentation of PAF-induced vasoconstriction and albumin flux in coronary arterioles.
    Huang Q; Wu M; Meininger C; Kelly K; Yuan Y
    Am J Physiol; 1998 Oct; 275(4):H1138-47. PubMed ID: 9746460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammatory cytokines cause coronary arteriosclerosis-like changes and alterations in the smooth-muscle phenotypes in pigs.
    Fukumoto Y; Shimokawa H; Ito A; Kadokami T; Yonemitsu Y; Aikawa M; Owada MK; Egashira K; Sueishi K; Nagai R; Yazaki Y; Takeshita A
    J Cardiovasc Pharmacol; 1997 Feb; 29(2):222-31. PubMed ID: 9057072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological profile of TCV-309--a potent PAF antagonist.
    Terashita Z; Takatani M; Nishikawa K
    J Lipid Mediat; 1992; 5(2):183-5. PubMed ID: 1445598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet-activating factor antagonist (TCV-309) attenuates the priming effects of bronchoalveolar macrophages in cerulein-induced pancreatitis rats.
    Yamaguchi Y; Matsumura F; Liang J; Okabe K; Matsuda T; Ohshiro H; Ishihara K; Akizuki E; Yamada S; Ogawa M
    Pancreas; 1999 May; 18(4):355-63. PubMed ID: 10231840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of the platelet-activating factor antagonist, TCV-309, and the cyclo-oxygenase inhibitor, ibuprofen, on the haemodynamic changes in canine experimental endotoxic shock.
    Yamanaka S; Iwao H; Yukimura T; Kim S; Miura K
    Br J Pharmacol; 1993 Dec; 110(4):1501-7. PubMed ID: 8306093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of platelet activating factor in development of thrombocytopenia and neutropenia in dogs with endotoxemia.
    Tsuchiya R; Kyotani K; Scott MA; Nishizono K; Ashida Y; Mochizuki T; Kitao S; Yamada T; Kobayashi K
    Am J Vet Res; 1999 Feb; 60(2):216-21. PubMed ID: 10048555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of platelet activating factor antagonist (TCV-309) on lung injury in dogs with experimentally endotoxin-induced shock.
    Okano S; Tagawa M; Urakawa N
    J Vet Med Sci; 1995 Aug; 57(4):751-3. PubMed ID: 8519912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Porcine coronary arteries with regenerated endothelium have a reduced endothelium-dependent responsiveness to aggregating platelets and serotonin.
    Shimokawa H; Aarhus LL; Vanhoutte PM
    Circ Res; 1987 Aug; 61(2):256-70. PubMed ID: 3113760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin 10 release during endotoxaemia in chimpanzees: role of platelet-activating factor and interleukin 6.
    van der Poll T; Jansen J; Levi M; ten Cate H; Hack CE; Aarden LA; ten Cate JW; van Deventer SJ
    Scand J Immunol; 1996 Jan; 43(1):122-5. PubMed ID: 8560191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet-activating factor (PAF) inhibitory profile of KO-286011 on blood platelets in vitro and in vivo.
    Ostermann G; Hofmann B; Kertscher HP; Till U
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Dec; 342(6):713-8. PubMed ID: 2096302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of platelet activating factor in ischaemia-reperfusion injury of isolated rabbit hearts: protective effect of a specific platelet activating factor antagonist, TCV-309.
    Katoh S; Toyama J; Kodama I; Koike A; Abe T
    Cardiovasc Res; 1993 Aug; 27(8):1430-4. PubMed ID: 8221795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet-activating factor (PAF) and PAF acetylhydrolase activity in rat uterus and placenta during the late stages of pregnancy.
    Matsubara T; Yasuda K; Johnston JM; Sanezumi M; Okada H; Matsuoka S; Kanzaki H
    Biol Reprod; 1997 Apr; 56(4):885-90. PubMed ID: 9096869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of prostaglandin of E, F and I series, leukotriene C and platelet activating factor on amylase release from isolated rat pancreatic acini.
    Jaworek J; Konturek SJ
    J Physiol Pharmacol; 1993 Dec; 44(4):365-81. PubMed ID: 7510150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.